Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report) and Celcuity (CELC – Research Report). Don't Miss our Black ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $19.32 which represents a decrease of $-1.53 or -7.34% from the prior close of $20.85. The stock opened at $21.34 and ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Hims & Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...